Roche hires med ed czar

Share this article:
Brian Russell, RPh, MBA, has been hired as director of medical education for Roche Laboratories—a new position—the company said.

Russell reports to Jean Fagan, MS.ED, MPH, leader, US scientific communications.

The job represents a change in direction for Russell, who spent 15 years prior at Philadelphia-based medical communications agency Vox Medica. He most recently served as partner and president of Vox Medica's accredited CME division, Institute for Continuing Healthcare Education.

Before that Russell, a registered pharmacist, served for six years as executive director of institutional extension services at Philadelphia School of Pharmacy and Science, which has since changed its name to the University of the Sciences in Philadelphia.

A Roche spokesperson said someone else had held the post briefly prior to Russell but that the position is essentially a new one within the Nutley, NJ, company's medical affairs department.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...